TKI Discontinuation Possible for Some CML Patients

Ahead of the 2017 ASCO Annual Meeting, we discuss the discontinuation of TKIs in some chronic myeloid leukemia patients.

Source: CancerNetwork - May 31, 2017 Category: Cancer & Oncology Authors: Ehab Atallah, MD Tags: Conferences/ASCO Hematology Chronic Myeloid Leukemia & Lymphoma Source Type: news